Advances in Immunopharmacology. Proceedings of the Second International Conference on Immunopharmacology, July 1982, Washington, USA

Content: 
Pergamon publications of related interest, Page ii
Front Matter, Page iii
Copyright, Page iv
Phenytoin and Humoral Immunity: Background and a Pharmacokinetic Interpretation of Recent Findings, Pages 3-9, P.W. MULLEN, M.L.S. QUEIROZ
Kinetics and Pharmacological Implications of MDP, Pages 11-16, M. PARANT
Biotransformation of Immunotherapeutic Agents, Pages 17-22, L.Z. BENET, S.Y. TSANG, U.F. LEGLER
Immunotoxicity of Tumor Promoting Environmental Chemicals and Phorbol Diesters, Pages 23-31, J.H. DEAN, M.I. LUSTER, G.A. BOORMAN, L.D. LAUER, E.C. WARD
Persistent Immune Dysfunction in Michigan Dairy Farm Residents Exposed to Polybrominated Biphenyls, Pages 33-39, J.G. BEKESI, J.P. ROBOZ, S. SOLOMON, J. ROBOZ, A. FISCHBEIN, I.J. SELIKOFF
The Lymphocyte as Target of Toxicity: a Biochemical Approach to Dialkyltin Induced Immunosuppression, Pages 41-60, A.H. PENNINKS, W. SEINEN
The Relationship between Early T Cell Activation Antigens and T Cell Proliferation, Pages 63-68, T. COTNER, J.L. STROMINGER, J.M. WILLIAMS, T.B. STROM
Membrane Fluidity and Enzyme Changes in Lymphocyte Activation, Pages 69-74, K. RESCH, M. GOPPELT, V. KAEVER, M. SZAMEL, W. URBACH, H.N. RODE
Membrane Methylation and other Early Biochemical Reactions in the Mitogen Activation of Lymphocytes, Pages 75-79, M.J. WAXDAL
The Role of Calcium and Arachidonic Acid Metabolism in Lymphocyte Activation, Pages 81-86, H.J. WEDNER
Calcium and Guanylate Cyclase in Lymphocyte Activation, Pages 87-94, R.G. COFFEY, J.W. HADDEN
Nuclear Activation and Regulation of Lymphocyte Protein Synthesis, Pages 95-100, H.L. COOPER, E.P. LESTER
Immunopharmacologic Applications of Monoclonal Antibodies to Human Lymphocytes, Pages 103-106, G. GOLDSTEIN
Characterization and Functions of Human T Cell Subsets, Pages 107-112, Y. THOMAS, L. ROGOZINSKI, L. CHESS
Monoclonal Antibodies in Cancer Diagnosis and Therapy, Pages 113-120, K.O. LLOYD
Monoclonal Antibodies in Bone Marrow Transplantation, Pages 121-128, G. JANOSSY, A.V. HOFFBRAND, H.G. PRENTICE, G. FRANCIS, N. TIDMAN, E. WOOD
Monoclonal Antibodies and Platelet Functions, Pages 129-134, J.P. CAEN, G. TOBELEM
Interferons: Immunopharmacological Considerations, Pages 137-141, W.E. STEWART II
Interferon and Inducers: Regulatory Effects on Cellular Functions, Pages 143-145, R.B. HERBERMAN, S.E. KROWN
Interferon and NK Cells, Pages 147-152, R.B. HERBERMAN, J.R. ORTALDO, C. RICCARDI, T. TIMONEN, A. SCHMIDT, A. MALUISH, J. DJEU
Short and Long Term Effect of Interferon in the Natural Cell Killer System, Pages 153-159, M. GIDLUND, L. RÖNNBLOM, H. WIGZELL, G. BRÄNNING
Autoregulation of Macrophage Cytotoxic Activity by Interferons and Prostaglandins, Pages 161-166, R.M. SCHULTZ
Antiviral and Antitumor Effects of Butyrate Salts Associated with an Immune Modulator and/or Interferon, Pages 167-172, C. CHANY, I. CERUTTI
Clinical Trials with Interferons in Patients with Cancer, Pages 173-178, S.E. KROWN
Role of Eosinophils in Resistance to Worm Infections, Pages 181-185, A.A.F. MAHMOUD
Immunopharmacology of Parasitic Diseases, Pages 187-193, J.P. DESSAINT, A. CAPRON, C. AURIAULT, C. MAZINGUE
Clinical Immunomodulation of Bacterial Infection, Pages 195-204, P.H. LAGRANGE
The Cause, Pathogenesis and Treatment of Subacute Sclerosing Panencephalitis, Pages 205-211, P.R. DYKEN, R.H. DURANT
Biochemical Correlates of Macrophage Activation, Pages 215-220, M. BAGGIOLINI, J. SCHNYDER, P.H. COOPER, W. RUCH, B. DEWALD
Lymphokine Induced Macrophage Proliferation: Purification and Characterization of Antigen Induced MGF/CSF, Pages 221-227, J.R. SADLIK, E.M. HADDEN, J.W. HADDEN
Transient Cytotoxic Responses of Activated Macrophages: Characterization of Signals that Regulate Cytotoxic Activity, Pages 229-234, M.S. MELTZER, C.A. NACY, S.L. JAMES, W.R. BENJAMIN, J.J. FARRAR
Systemic Activation of Macrophages and Treatment of Cancer Metastases by Liposomes containing Hydrophilic or Lipophilic Muramyl Dipeptide, Pages 235-241, I.J. FIDLER, W.E. FOGLER, A.J. SCHROIT, G. SCHUMANN, D.G. BRAUN, A.J. SCHROIT
Regulation of Macrophage Function by Lymphokines Role of Membrane Phospholipids, Pages 243-249, E. PICK, Y. BROMBERG
Regulation of the Tumoricidal and Suppressive Activity of Human Macrophages, Pages 251-256, A. BIONDI, C. BORDIGNON, G. PERI, M.B. DONATI, E. VICENZI, P. GHEZZI, M. SALMONA, A. MANTOVANI
Autacoids for Immune Modulation: a Strategy, Pages 259-267, K. MELMON, R. ROSENKRANZ, M. VERLANDER, M. GOODMAN
Some Selected Aspects of the Immunopharmacology of Adrenoceptors, Pages 269-276, A. SZENTIVANYI, J. SZENTIVANYI
Applications of Flow Cytometry to the Study of Immunology and Immune Diseases, Pages 277-286, A.D. STEINBERG
Signal Transduction Mechanisms: Peptide Hormone — Receptor Cross Linking, Internalization, and Lysosomal Processing, Pages 287-292, A.C. KING
Immunologic Disturbances of Receptors in Diseases, Pages 293-297, J.F. BACH
T-T Cell Interactions in the Regulation of the Antibody Response: The Role of I Region Products on T Cells, Pages 301-306, T. TADA, K. HIRAMATSU, M. NONAKA, S MIYATANI, R. ABE
Thymus and T Cell Alterations in Murine Lupus: Immunological and Pharmacological Effects of Thymus Replacement, Pages 307-313, M.A. BACH
Generation of Monoclonal Human Antigen-specific T Cell Helper Factors, Pages 315-319, J. WOODY, R. HARTZMAN, J. LAMB, D. ECKELS, P. LAKE, A. JOHNSON, A. FISCHER, E. ZANDERS, P. BEVERLEY, M. FELDMAN
Current Therapy of Rheumatoid Arthritis, Pages 323-328, Y. SHIOKAWA
Present Status of Pharmacotherapy of Autoimmune Diseases, Pages 329-336, P.A. MIESCHER, Ph. BERIS, Y.-P. HUANG
Therapeutic Models of Systemic Lupus Erythematosus (SLE), Pages 337-344, N. TALAL, M. FISCHBACH
Immunopharmacology of Remission-inducing Drugs in Rheumatoid Arthritis, Pages 345-350, P.E. LIPSKY
Immunologie Aspects of Multiple Sclerosis, Pages 351-355, B.H. WAKSMAN
Current Aspects of Chronic Inflammation, Pages 357-362, J.L. TURK
Early Events in Neutrophil Chemotactic Factor Interaction, Pages 365-370, E.L. BECKER, R.J. FREER, W.M. MAGKIN, P.H. NACCACHE, R.A. SHA'AFI
Modulation of the Chemoattractant Receptor for fmet-leu-phe during Neutrophil Activation, Adaptaion and Deactivation, Pages 371-377, J.I. GALLIN, M.P. FLETCHER, B.E. SELIGMANN, H. DONABEDIAN
Superoxide and Oxygen-Dependent Killing by Phagocytes, Pages 379-384, B.M. BABIOR
The Stimulation of Leukocytes In Vivo, Pages 385-390, C.G. COCHRANE, S.D. REVAK, I.S. SCHRAUFSTATTER, R.G. SPRAGG
Methylation Reactions in the Regulation of Mononuclear Phagocyte Function, Pages 391-397, M.G. PIKE, R. SNYDERMAN
Adjuvants for Vaccines, Pages 401-406, L. CHEDID
Chemistry and Immunology of Native and Synthetic Peptide Fragments of Streptococcal M Proteins, Pages 407-414, E.H. BEACHEY, J.B. DALE, D.L. HASTY, A.H. KANG, J.M. SEYER, W.A. SIMPSON
New Approaches for Contraceptive Vaccine, Pages 415-420, G.P. TALWAR, S.K. GUPTA, O. SINGH, V. SINGH, C. DAS
Anti-influenza Response Induced with Synthetic Antigen, Pages 421-427, R. ARNON, M. JIBSON, G. MÜLLER, M. SHAPIRA
Use of MDP with Diphtheric or other Synthetic Oligopeptides as a Model for Totally Synthetic Vaccines, Pages 429-434, F. AUDIBERT, M. JOLIVET, C. CARELLI
Perspective Offered by Genetic Engineering in the Development of New Vaccines against Hepatitis B, Pages 435-439, P. TIOLLAIS, C. POURCEL, G. CARLONI, G. CARLONI, M.L. MICHEL, E. SOBZACK, Y. MALPIECE
The Effect of Brain Stem Lesions on the Immune Response, Pages 443-450, K. MAŚEK, O. KADLECOV, A.P. PETROVICKÝ
Neuroimmunomodulation: the Evidence, Pages 451-456, N.H. SPECTOR
Neuroendocrine Immunoregulatory Circuits, Pages 457-462, H.O. BESEDOVSKY, A. DEL REY, E. SORKIN
Immunochronopharmacology, Pages 463-478, F. HALBERG, S.S. DE LA PENA, G. FERNANDES
Behaviorally Conditioned Immunosuppression: Effects on the Course of Autoimmune Disease in New Zealand Hybrid Mice, Pages 479-484, R. ADER, N. COHEN
Immunotherapy of Human Cancer: Current Status and Prospects for Future Development, Pages 487-499, E.M. HERSH
Cancer Immunotherapy in Japan, Pages 501-507, Y. YAMAMURA, I. AZUMA
Evaluation of Criteria to be met for Effective Tumour Immunotherapy, Pages 509-515, R.W. BALDWIN
Clinical Applications of Acute Phase Proteins, Pages 517-524, P.B. CHRETIEN, J.F. WEISS
The Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation, Pages 527-534, B. SAMUELSSON
Inhibitors of the Arachidonic Acid Cascade, Pages 535-541, J.R. VANE
Characteristics of Human Leukocyte Receptors for Leukotrienes, Pages 543-548, W. PICKETT, D.W. GOLDMAN, E.J. GOETZL
In Vivo and In Vitro Actions of a New Selective Inhibitor of Leukotriene C and D Synthesis, Pages 549-554, M.K. BACH, J.R. BRASHLER, R.L. GRIFFIN, S.S. IDEN, H.G. JOHNSON, M.L. McNEE, H.W. SMITH, R.J. SMITH, F.A. FITZPATRICK, J.C. McGUIRE, F.F. SUN, M.A. WASSERMAN
Free Radical Mechanisms, Pages 555-562, F.A. KUEHL Jr., R.W. EGAN, H.W. DOUGHERTY, J.L. HUMES
Platelet-activating Factor (PAF-acether), Pages 565-571, J. BENVENISTE
C-reactive Protein and other Acute Phase Reactants, Pages 573-578, M.B. PEPYS
Endogenous Pyrogen, Pages 579-584, M.J. KLUGER, J.G. GANNON
Hageman Factor-dependent Pathways and Bradykinin Formation, Pages 585-590, A.P. KAPLAN
The Biology of the Interleukins, Pages 593-596, A.L. DE WECK, F. KRISTENSEN, F. BETTENS, F. JONCOURT
Characterization and Mechanism of Action of Soluble Immune Response Suppressor (SIRS), Pages 597-602, T.M. AUNE, C.W. PIERCE
Macrophage Evolution and Interactions with Lymphokines, Pages 603-607, C. SORG, C. NEUMANN, U. MALORNY, E. MICHELS, W. STENZINGER
Lymphokines Mediate and Regulate In Vivo Delayed Hypersensitivity Reactions, Pages 609-614, T. YOSHIDA
Lipoxygenase Products of Arachidonic Acid: their Role in Inflammatory Events Mediated by Human Basophils and Mast Cells, Pages 617-622, S.P. PETERS, R.P. SCHLEIMER, D.W. MacGLASHAN Jr., E.S. SCHULMAN, A. KAGEY-SOBOTKA, G.K. ADAMS III, L.M. LICHTENSTEIN
Methylation of Membrane Phospholipid in Mast Cell Activation, Pages 623-628, T. ISHIZAKA
T Cell Regulation of IgE Synthesis in Atopic Patients, Pages 629-635, Z. HEMADY, R.E. ROCKLIN
Mast Cell Neutral Proteases, Pages 637-643, L.B. SCHWARTZ
IgE Receptor and cAMP in Mast Cell Activation, Pages 645-652, C.M. WINSLOW, K.F. AUSTEN
Biological Response Modifiers Program, Pages 655-660, R.K. OLDHAM
In Vivo Functional Characterization of Immunomodulators, Pages 661-668, I. FLORENTIN, L. KRAUS, M. BRULEY-ROSSET, G. MATHÉ
Characterization of Agents, Pages 669-677, M.A. CHIRIGOS, E. SCHLICK, M. PICCOLI, E. READ, K. HARTUNG, A. BARTOCCI
Characterization of Immunomodulation, Pages 679-684, C. ABE
Perspectives of Drugs obtained by Recombinant DNA Technology, Pages 685-690, N. STEBBING
Characterization of Immunotherapeutic Agents: an Overview, Pages 691-699, J.W. HADDEN
Pharmacological and Cellular Interactions in Bone Resorption, Pages 703-707, T.J. CHAMBERS, D.A. WILLOUGHBY, C.J. DUNN
Modification of Macrophages and Lymphocytes Functions during Non Specific Acute Inflammation, Pages 709-717, J.P. GIROUD, Y. SHENG, M. PELLETIER, J. BIRD, I. FLORENTIN
Interaction between Macrophages and Lymphocytes, Pages 719-723, J. MORLEY
The Role of Catabolins in Synovia-Chondrocyte Interactions, Pages 725-729, J.T. DINGLE
Osteoclasts and Arthritis, Pages 731-736, E.P. AMENTO, S.R. GOLDRING, S.M. KRANE, J.T. KURNICK
Lymphocyte Constituents in Inflammation, Pages 737-742, J. GARCIA-LEME
On the Mode of Action of Immunodepressive Agents, Pages 745-752, F. SPREAFICO, A. ALBERTI, M. ALLEGRUCCI, A. GANEGRATI, F. COLOTTA, W. LUINI, A. MERENDINO, E. PASQUALETTO, M. ROMANO, M. SIRONI, A. VECCHI
Clinical Effects of Immunosuppressive Agents: Targets and Mechanisms, Pages 753-758, T.R. CUPPS, A.S. FAUCI
New Approaches in Transplantation — Organ Rejection, Pages 759-763, J.R. BATCHELOR
Purification and Analysis of Antigen-specific Suppressor Proteins derived from T-Cell, Pages 765-771, D.R. WEBB, E. GERASSI, C. HEALY, K. KRUPEN, I. NOWOWIEJSKI, C.M. SORENSEN, S. STEIN, K.J. WIEDER, B.A. ARANEO, J.A. KAPP, C.W. PIERCE
Infection and Immunosuppression, Pages 773-783, H. FRIEDMAN, T.W. KLEIN, S. SPECTER
Aging: a Natural Immunomodulator, Pages 785-790, T. MAKINODAN, K. ONARI, K. SATO, T. AKAGAWA, W.J. PETERSON
Monoclonal Antibodies, Pages 793-797, H.E. BLYTHMAN, J.W. UHR
Glucans I, Pages 799-804, N.R. DI LUZIO, G. CHIHARA
Immunopotentiators I, Pages 805-808, M.A. CHIRIGO, P. CHRETIEN
Immunopotentiators II Imuthiol (Sodium Diethyldithiocarbamate), Isoprinosine, NPT 15392, NPT 16416 and LF 1695, Pages 809-816, G. RENOUX, J. WYBRAN
Control of Leukotriene and Prostaglandin Action, Pages 817-819, R. PAOLETTI, M.K. BACH
Peptidoglycans, Pages 821-831, Fr. OBERLING, S. KOTANI
Immunotoxicology, Pages 833-838, J.H. DEAN, P. DUKOR
Biological Response Modifiers: Selected Topics, Pages 839-844, E. MIHICH, H. FRIEDMAN
Antiallergy Therapy, Pages 845-852, E. MIDDLETON Jr., W. DAWSON
Immunosuppression, Pages 853-861, G.H. WERNER, J.R. BATTISTO
Therapy of Infections and Immunodeficiency Diseases, Pages 863-865, A. JOHNSON, J.-L. TOURAINE
Lymphokines, Pages 867-869, J.E. McENTIRE, D. DUMONDE
Author Index, Pages 871-873
Subject Index, Pages 875-878